D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Biogen
BIIB
|
+$458M |
| 2 |
Apple
AAPL
|
+$445M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$417M |
| 4 |
LNKD
LinkedIn Corporation
LNKD
|
+$245M |
| 5 |
Union Pacific
UNP
|
+$221M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$669M |
| 2 |
Meta Platforms (Facebook)
META
|
+$478M |
| 3 |
Marathon Petroleum
MPC
|
+$469M |
| 4 |
Valero Energy
VLO
|
+$456M |
| 5 |
DuPont de Nemours
DD
|
+$451M |
Sector Composition
| 1 | Healthcare | 16.27% |
| 2 | Communication Services | 11.84% |
| 3 | Technology | 11.37% |
| 4 | Energy | 10.36% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZAYO
751
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $7.51M | 0.01% |
282,298
+257,307
| +1,030% | +$6.84M |
|
752
Southern Company
SO
$101B
| $7.49M | 0.01% |
160,147
-556,775
| -78% | -$26.1M |
|
753
FibroGen
FGEN
$49.3M
| $7.48M | 0.01% |
9,816
+2,115
| +27% | +$1.61M |
|
754
Melco Resorts & Entertainment
MLCO
$3.87B
| $7.48M | 0.01% |
445,023
-61,959
| -12% | -$1.04M |
|
|
STOR
755
DELISTED
STORE Capital Corporation
STOR
| $7.48M | 0.01% |
322,234
+183,744
| +133% | +$4.26M |
|
756
PACCAR
PCAR
$53.4B
| $7.45M | 0.01% |
235,731
+219,708
| +1,371% | +$6.94M |
|
757
Expeditors International
EXPD
$16.7B
| $7.44M | 0.01% |
164,971
-271,101
| -62% | -$12.2M |
|
758
Regis Corp
RGS
$66.9M
| $7.42M | 0.01% |
26,215
+3,274
| +14% | +$927K |
|
759
Spire
SR
$4.51B
| $7.42M | 0.01% |
124,818
-45,206
| -27% | -$2.69M |
|
760
Veeco
VECO
$1.56B
| $7.4M | 0.01% |
360,092
+67,092
| +23% | +$1.38M |
|
761
Rigel Pharmaceuticals
RIGL
$664M
| $7.39M | 0.01% |
244,000
+14,650
| +6% | +$444K |
|
|
ACOR
762
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $7.36M | 0.01% |
1,433
+1,184
| +476% | +$6.08M |
|
|
ARIA
763
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $7.34M | 0.01% |
1,173,631
+1,017,660
| +652% | +$6.36M |
|
764
Arthur J. Gallagher & Co
AJG
$76.7B
| $7.33M | 0.01% |
178,944
+4,776
| +3% | +$196K |
|
765
Cintas
CTAS
$82.1B
| $7.3M | 0.01% |
320,876
-133,248
| -29% | -$3.03M |
|
766
BRF SA
BRFS
$6.07B
| $7.29M | 0.01% |
527,388
-470,232
| -47% | -$6.5M |
|
|
KCG
767
DELISTED
KCG Holdings, Inc.
KCG
| $7.29M | 0.01% |
592,062
+119,583
| +25% | +$1.47M |
|
|
WBC
768
DELISTED
WABCO HOLDINGS INC.
WBC
| $7.29M | 0.01% |
71,267
+49,665
| +230% | +$5.08M |
|
|
ZIONW
769
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $7.28M | 0.01% |
2,148,700
| – | – |
|
|
NCI
770
DELISTED
Navigant Consulting, Inc.
NCI
| $7.27M | 0.01% |
452,600
+73,605
| +19% | +$1.18M |
|
|
CALD
771
DELISTED
Callidus Software, Inc.
CALD
| $7.25M | 0.01% |
390,537
+122,139
| +46% | +$2.27M |
|
772
Acco Brands
ACCO
$370M
| $7.24M | 0.01% |
1,014,700
-64,262
| -6% | -$458K |
|
773
Live Nation Entertainment
LYV
$40.3B
| $7.18M | 0.01% |
292,195
+133,333
| +84% | +$3.28M |
|
774
Ashland
ASH
$2.46B
| $7.15M | 0.01% |
142,211
-21,818
| -13% | -$1.1M |
|
775
Nomura Holdings
NMR
$22.1B
| $7.12M | 0.01% |
1,282,492
+41,953
| +3% | +$233K |
|